2023
DOI: 10.1176/appi.neuropsych.20220116
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Comorbid Anxiety and Epilepsy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 99 publications
0
1
0
Order By: Relevance
“…Although the evidence base is low, it is intuitive to use an ASM for psychiatric comorbidity in epilepsy, particularly if complementary mechanisms may improve seizures and psychiatric symptoms simultaneously [29] . Some of the most robust findings for ASMs in treating anxiety include lamotrigine and clobazam [30] . Although risks and benefits would need to be considered, in Abby’s case, improving seizure control would be an important goal and suggests that adjunctive ASMs with the added benefit of improving anxiety symptoms would be preferred options.…”
Section: Treatment Strategiesmentioning
confidence: 99%
“…Although the evidence base is low, it is intuitive to use an ASM for psychiatric comorbidity in epilepsy, particularly if complementary mechanisms may improve seizures and psychiatric symptoms simultaneously [29] . Some of the most robust findings for ASMs in treating anxiety include lamotrigine and clobazam [30] . Although risks and benefits would need to be considered, in Abby’s case, improving seizure control would be an important goal and suggests that adjunctive ASMs with the added benefit of improving anxiety symptoms would be preferred options.…”
Section: Treatment Strategiesmentioning
confidence: 99%